160 related articles for article (PubMed ID: 11788598)
1. Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcription.
Shamay M; Barak O; Doitsh G; Ben-Dor I; Shaul Y
J Biol Chem; 2002 Mar; 277(12):9982-8. PubMed ID: 11788598
[TBL] [Abstract][Full Text] [Related]
2. Functional interaction between nuclear matrix-associated HBXAP and NF-kappaB.
Huang JY; Shen BJ; Tsai WH; Lee SC
Exp Cell Res; 2004 Aug; 298(1):133-43. PubMed ID: 15242768
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus pX targets TFIIB in transcription coactivation.
Haviv I; Shamay M; Doitsh G; Shaul Y
Mol Cell Biol; 1998 Mar; 18(3):1562-9. PubMed ID: 9488473
[TBL] [Abstract][Full Text] [Related]
4. HBXAP, a novel PHD-finger protein, possesses transcription repression activity.
Shamay M; Barak O; Shaul Y
Genomics; 2002 Apr; 79(4):523-9. PubMed ID: 11944984
[TBL] [Abstract][Full Text] [Related]
5. Direct association and nuclear import of the hepatitis B virus X protein with the NF-kappaB inhibitor IkappaBalpha.
Weil R; Sirma H; Giannini C; Kremsdorf D; Bessia C; Dargemont C; Bréchot C; Israël A
Mol Cell Biol; 1999 Sep; 19(9):6345-54. PubMed ID: 10454581
[TBL] [Abstract][Full Text] [Related]
6. Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX.
Natoli G; Avantaggiati ML; Chirillo P; Costanzo A; Artini M; Balsano C; Levrero M
Mol Cell Biol; 1994 Feb; 14(2):989-98. PubMed ID: 7507209
[TBL] [Abstract][Full Text] [Related]
7. Identification of a nuclear protein that promotes NF-kappaB activation.
Chen D; Li Z; Yang Q; Zhang J; Zhai Z; Shu HB
Biochem Biophys Res Commun; 2003 Oct; 310(3):720-4. PubMed ID: 14550261
[TBL] [Abstract][Full Text] [Related]
8. Evidence of a transcriptional co-activator function of cohesin STAG/SA/Scc3.
Lara-Pezzi E; Pezzi N; Prieto I; Barthelemy I; Carreiro C; Martínez A; Maldonado-Rodríguez A; López-Cabrera M; Barbero JL
J Biol Chem; 2004 Feb; 279(8):6553-9. PubMed ID: 14660624
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins.
Furia B; Deng L; Wu K; Baylor S; Kehn K; Li H; Donnelly R; Coleman T; Kashanchi F
J Biol Chem; 2002 Feb; 277(7):4973-80. PubMed ID: 11739381
[TBL] [Abstract][Full Text] [Related]
10. Centrosomal P4.1-associated protein is a new member of transcriptional coactivators for nuclear factor-kappaB.
Koyanagi M; Hijikata M; Watashi K; Masui O; Shimotohno K
J Biol Chem; 2005 Apr; 280(13):12430-7. PubMed ID: 15687488
[TBL] [Abstract][Full Text] [Related]
11. The X protein of hepatitis B virus coactivates potent activation domains.
Haviv I; Vaizel D; Shaul Y
Mol Cell Biol; 1995 Feb; 15(2):1079-85. PubMed ID: 7823923
[TBL] [Abstract][Full Text] [Related]
12. A novel zinc finger protein TReP-132 interacts with CBP/p300 to regulate human CYP11A1 gene expression.
Gizard F; Lavallée B; DeWitte F; Hum DW
J Biol Chem; 2001 Sep; 276(36):33881-92. PubMed ID: 11349124
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction.
Zheng Y; Ming P; Zhu C; Si Y; Xu S; Chen A; Wang J; Zhang B
J Biol Chem; 2019 Mar; 294(13):4815-4827. PubMed ID: 30659097
[TBL] [Abstract][Full Text] [Related]
14. FBI-1 enhances transcription of the nuclear factor-kappaB (NF-kappaB)-responsive E-selectin gene by nuclear localization of the p65 subunit of NF-kappaB.
Lee DK; Kang JE; Park HJ; Kim MH; Yim TH; Kim JM; Heo MK; Kim KY; Kwon HJ; Hur MW
J Biol Chem; 2005 Jul; 280(30):27783-91. PubMed ID: 15917220
[TBL] [Abstract][Full Text] [Related]
15. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
[TBL] [Abstract][Full Text] [Related]
16. PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit.
Jang HD; Yoon K; Shin YJ; Kim J; Lee SY
J Biol Chem; 2004 Jun; 279(23):24873-80. PubMed ID: 15140884
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
Chan CF; Yau TO; Jin DY; Wong CM; Fan ST; Ng IO
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4140-9. PubMed ID: 15217951
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel A20-binding inhibitor of nuclear factor-kappa B activation termed ABIN-2.
Van Huffel S; Delaei F; Heyninck K; De Valck D; Beyaert R
J Biol Chem; 2001 Aug; 276(32):30216-23. PubMed ID: 11390377
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional coactivation of nuclear factor-kappaB-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1.
Hassa PO; Buerki C; Lombardi C; Imhof R; Hottiger MO
J Biol Chem; 2003 Nov; 278(46):45145-53. PubMed ID: 12960163
[TBL] [Abstract][Full Text] [Related]
20. pX, the HBV-encoded coactivator, suppresses the phenotypes of TBP and TAFII250 mutants.
Haviv I; Matza Y; Shaul Y
Genes Dev; 1998 Apr; 12(8):1217-26. PubMed ID: 9553050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
